More attacks on Lundbeck's big seller

One of pharmaceutical company Lundbeck's best-selling drugs is drowning in generics.

Photo: Gregers Tycho/ERH

Generics companies have been throwing themselves at Danish pharmaceutical company Lundbeck's billion-kroner selling drug Northera, according to data collected by Danish business media Finans.

A total of 12 companies have received authorization to market generics of Lundbeck's big seller, out of which 8 already have products on the market.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Further reading

Related articles

Latest news

See all jobs